Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to 28 Years

Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to 28 Years

BackgroundHow anti-mitochondrial antibody (AMA) and liver biochemistry levels change in primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains unclear.MethodsA 28-year cohort of 157 PBC patients was conducted. Patients with alkaline phosphatase (Alk-p) levels &am...

Full description

Bibliographic Details
Main Authors: Ming-Ling Chang, Wei-Ting Chen, Tien-Ming Chan, Cheng-Yu Lin, Ming-Yu Chang, Shiang-Chi Chen, Rong-Nan Chien
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Immunology
Subjects:
antimitochondrial antibodies (AMA)
primary biliary cholangitis (PBC)
UDCA
alkaline phospatase
cirrhosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.869018/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.869018/full

Similar Items